Current methods of pharmacologic stress testing and the potential advantages of new agents

Journal of Nuclear Medicine Technology

Volumn 37, Issue 1, 2009, Pages 14-25

  Botvinick, Elias H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiology (clinical); Coronary artery disease; MRI; Perfusion scintigraphy; Pharmacologic stress; SPECT CT; Stress testing; Vasodilator

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BINODENOSON; CAFFEINE; DIPYRIDAMOLE; DOBUTAMINE; LEXISCAN; PAPAVERINE; RADIOISOTOPE; REGADENOSON; STEROID; THEOPHYLLINE; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ANGINA PECTORIS; BODY WEIGHT; BRONCHOSPASM; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIZZINESS; DRUG STRUCTURE; DYSPNEA; EXERCISE; EXERCISE TEST; FLUSHING; FOOD AND DRUG ADMINISTRATION; HALF LIFE TIME; HEADACHE; HEART ARRHYTHMIA; HEART BLOCK; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; HEAT; HUMAN; HYPOTENSION; METHODOLOGY; NAUSEA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RECEPTOR BINDING; REVIEW; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SYMPTOM; THORAX PAIN; VASODILATATION;

ADENOSINE; ANIMALS; CORONARY DISEASE; DOBUTAMINE; EXERCISE TEST; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PURINES; PYRAZOLES; RECEPTORS, ADENOSINE A2; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 62649131104     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.108.057802     Document Type: Review

References (37)

1. Gould KL, Libscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974; 33:87-95.
2. Sigwart U, Grbic M, Payot M. Ischemic events during coronary artery balloon obstruction. In: Rutishauser W, Roskamm H, eds. Silent Myocardial Ischemia. Berlin, Germany: Springer-Verlag; 1984:29-36.
3. Botvinick EH. Stress imaging: current clinical options for the diagnosis, localization and evaluation of coronary artery disease. Med Clin N Amer. 1995;79:1025-1061.
4. Verna E, Ceriani L, Provasoli S, Scotti S, Ghiringhelli S. Larger perfusion defects with exercise compared with dipyridamole SPECT (exercise-dipyridamole mismatch) may reflect differences in epicardial and microvascular coronary dysfunction: when the stressor matters. J Nucl Cardiol. 2007;14:818-826.
5. Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. J Nucl Med. 1994;35:535-541.
6. Levine MG, Ahlberg AW, Mann A, et al. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol. 1999;6:389-396.
7. Chow BJ, Beanlands RS, Lee A, et al. Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. J Am Coll Cardiol. 2006;47:411-416.
8. Kugiyama K, Ohgushi M, Motoyama T, et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol. 1997;30:920-926.
9. David N, Marie PY, Angioi M, et al. Dipyridamole and exercise SPET provide different estimates of myocardial ischaemic areas: role of the severity of coronary stenoses and of the increase in heart rate during exercise. Eur J Nucl Med. 2000;27:788-799.
10. Verani MS. Adenosine thallium-201 myocardial perfusion scintigraphy. Am Heart J. 1991;122:269-278.
11. Lapeyre AC III, Goraya TY, Johnston DL, Gibbons RJ. The impact of caffeine on vasodilator stress perfusion studies. J Nucl Cardiol. 2004;11:506-511.
12. Müller-Suur R, Eriksson SV, Strandberg LE, Mesko L. Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on beta-blocker therapy. Cardiology. 2001;95:112-118.
13. Mahmarian JJ, Shaw LJ, Olszewski GH, Pounds BK, Frias ME, Pratt CM. Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: a randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction. J Nucl Cardiol. 2004;11:458-469.
14. Mahmarian JJ, Shaw LJ, Filpchuk NG, et al. for the INSPIRE Investigators. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol. 2006;48:2448-2457.
15. Mahmarian JJ, Dakik HA, Filpchuk NG, et al. for the INSPIRE Investigators. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol. 2006;48:2458-2470.
16. Dhalla AK, Wong MY, Wang L, Belardinelli CV. Mechanism of tachycardia during myocardial perfusion imaging with adenosine [abstract]. J Nucl Cardiol. 2004;11(suppl):S2.
17. HollyTA, SatranA, BrometDS, etal. Theimpactofadjunctiveadenosineinfusion during exercise myocardial perfusion imaging: results of the Both Exercise and Adenosine Stress Test(BEAST) trial. J Nucl Cardiol. 2003;10:291-296.
18. Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS, Quality Assurance Committee of the American Society of Nuclear Cardiology. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80-e90.
19. Klocke FJ. Coronary blood flow in man. Prog Cardiovasc Dis. 1976;19: 117-166.
20. Hoffman JIE, Baer RW, Hanley FL, et al. Regulation of transmural myocardial blood flow. J Biomech Eng. 1985;107:2-9.
21. Kern MJ. Walking with Sir William: reflections on collateral steal, recruitment, and ischemic protection. J Am Coll Cardiol. 2006;48:66-69.
22. Cosmai EM, Heller GV. The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging. J Nucl Cardiol. 2005;12:466-472.
23. Martin TW, Seaworth JF, Johns JP, et al. Comparison ofadenosine, dipyridamole and dobutamine in stress echocardiography. Ann Intern Med. 1992;116:190-196.
24. Jagathesen R, Barnes E, Rosen SD, Foale RA, Camici PG. Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: implications for pharmacologic stress testing in coronary artery disease. J Nucl Cardiol. 2006;13:324-332.
25. Lattanzi F, Picano E, Adamo E, Varga A. Dobutamine stress echocardiography: safety in diagnosing coronary artery disease. Drug Saf. 2000;22:251-262.
26. Sato A, Terata K, Miura H, et al. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol. 2005;288:H1633-H1640.
27. Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004;94:33D-40D.
28. Hendel RC, Jamil T, Glover DK. Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol. 2003;10:197-204.
29. 2a agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J AmColl Cardiol. 2005;46:2069-2075.
30. A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation. 2004;109:457-464.
31. 2A agonists. J Pharmacol Exp Ther. 2001;298:209-218.
32. A adenosine receptor. Nucleosides Nucleotides Nucleic Acids. 2001;20:343-360.
33. Zhao G, Linke A, Xu X, et al. Comparative profile of vasodilation by CVT-3146: a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther. 2003;307:182-189.
34. Glover DK, Ruiz M, Yang JY, et al. Pharmacologic stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470): a novel, short-acting adenosine A2A receptor agonist. Circulation. 1996;94:1726-1732.
35. Iskandrian AE, Bateman TM, Belardinelli L, et al. for the ADVANCE MPI Investigators. Adenosine versus regadenoson comparative evaluation in myo- cardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645-658.
36. 2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008;15:319-328.
37. 2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol. 2008;15:329-336.